mRNA COVID-19 Vaccines Offer Strong Protection to Expectant Mothers
Pregnant women were excluded from trials demonstrating safety and effectiveness of mRNA COVID-19 vaccines, even though expectant mothers are at high risk for severe COVID-19. That is why the first large, real-world study in that cohort is so important. Learn more about this study and how much protection the COVID-19 vaccines provided to expectant mothers.

RZV Reduces Herpes Zoster Pain in Breakthrough Cases
Neuropathic pain of postherpetic neuralgia can be devastating for herpes zoster patients. That is why vaccination preventing the infection is so strongly urged. A new study published in the journal Pain demonstrated that—even in rare breakthrough herpes zoster cases—vaccination with the adjuvanted recombinant zoster vaccine (RZV) significantly reduces pain. Learn more about this study.

Should Pneumococcal Conjugate Vaccine Use Expand?
High rates of antimicrobial resistance in adults with pneumococcal disease is a continuing and troubling issue. That led the authors of a new study published in Open Forum Infectious Diseases to call for use of higher valent pneumococcal conjugate vaccines and to expand the recommendation of who receives those vaccines to include adults aged 50 to 64 years. Read more.